Search results for

Precision medicine, also known as personalised medicine, is an emerging field in healthcare and seems to have a promising future as it accounts for 42% of new molecular entities which the Food and Drug Administration (FDA) approved in 2018. Since precision medicine aims to provide bespoke medical treatments based on individual patient's characteristics, it essentially incorporates diagnosis and treatment methods. Under Korean patent law and practice, treatment and diagnosis methods are not considered patent eligible subject matter. As such, it is necessary to circumvent restrictive eligibility requirements to obtain protection for precision medicines in Korea. In the past, although precision medicines can be pursued as a pharmaceutical/diagnostic composition claim, it was not easy to claim methodological aspects of precision medicines (e.g. dosage regimen) which were not considered as technical features constituting composition itself (Supreme Court decisions 2007Hu2926 and 2007Hu2933, rendered on May 28 2009).

The reform of August 10 2018 to the Mexican Industrial Property Law substantially changed the Mexican trademark landscape. Among the most relevant changes brought by this legislative reform, particularly the acceptance on behalf of the Mexican Institute of Industrial Property (IMPI) of non-conventional trademark applications – such as smell and sound trademarks – positions Mexico today at the forefront of innovation.

In In re TracFone Wireless, Inc., the Trademark Trial and Appeal Board (TTAB) issued yet another decision finding that a particular designation fails to function as a mark – the subject of over 21% of precedential rulings this year. These decisions highlight the importance of brand owners, marketing teams, advertising departments and legal counsel coordinating effectively.

Foreign applications for trademarks and designs are on the up, according to the UKIPO’s annual report, which also shows a decline in patent applications and a focus on workplace wellbeing

Nigel Swycher, CEO of patent analysis software company Cipher, looks ahead to the IP Corporate Strategy Summit 2019

Some of Canada’s changes to its patent law will have a big impact on companies’ strategies, according to lawyers, but it’s “business as usual” for now

Mr Justice Henry Carr, an IP judge at the England & Wales High Court who was “utterly devoid of pomposity,” has sadly passed away

In-house counsel consider whether a new IP right for software inventions could help the UK compete after Brexit and discuss whether IP is enough of a priority for decision makers

With the news that Mr Justice Arnold is to join the England & Wales Court of Appeal, Managing IP speaks to lawyers to assess the judge’s impact on IP law and asks who his replacement might be

Lawyers at Gedeon Richter, F-Star and Siemens say they are happy to see a focus on employee satisfaction in the 2023 Strategic Plan, but would also like to see a higher emphasis on quality